CSI Market
Sign In | Register

Point Biopharma Global Inc (PNT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PNT Annual Balance Sheets →
Looking at balance sheet data from Point Biopharma Global Inc through Sep 30 2022 provides insight into Sep 30 2023's solvency and capital structure over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2023)
(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Assets
Cash & cash equivalent21.61
Short-term Investments, Total317.56
Cash & Short-term Investments338.00
Income Taxes Receivable, Current NO4.18
Other Current Assets0.00
Prepaid Expense And Other Assets Current9.90
Total Current Assets353.25
Equipment/Property/Plant Net0.00
Long-term investments59.79
Notes, Loans and Financing Receivable, Net, Noncurrent LO5.12
Other Assets, Noncurrent1.00
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization54.04
Operating Lease Right Of Use Asset5.51
Total Assets477.70
Liabilities
Accounts Payable, Current AC8.89
Accrued Liabilities, Current AC14.53
Other Liabilities, Current14.51
Taxes Payable, Current, Total0.74
Total Current Liabilities38.67
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent AC12.39
Other liabilities, Noncurrent12.46
Contract With Customer Liability Current12.59
Operating Lease Liability Current0.94
Contract With Customer Liability Noncurrent3.72
Total Liabilities53.51
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock453.32
Retained Earnings / Accumulated Deficit-27.71
Other Equity-1.43
Common Stockholder's Equity424.19
Total Stockholder's Equity424.19
Liabilities & Stockholder's Equity477.70
4 historic quarters locked

Sign in to unlock the full Point Biopharma Global Inc balance sheet history.

Sign In Create Free Account

About Point Biopharma Global Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001811764-23-000046

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.